Drugs / Tocotrienol-rich fraction vitamin E
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05905185 | Jan 2020 → Jan 2022 | obesity disorder | National University of Malaysia | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tocotrienol-rich fraction vitamin E | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05905185 ↗ |
| Known as | TRF | “Participants will : 1. consume daily either a dose of 50 mg of tocotrienol-rich fraction (TRF) vitamin E or a placebo for 6 months.” NCT05905185 ↗ |
| Route | Oral | “During a period of six months, the patients were instructed to consume oral TRF (50 mg) daily” NCT05905185 ↗ |